Skip to ContentSkip to Navigation
How to find us J.E. Heida


Effect of Vasopressin on the Hypothalamic-Pituitary-Adrenal Axis in ADPKD Patients during V2 Receptor Antagonism

No Change in Nocturia After NOCTURNE

Urine-to-plasma urea ratio, as surrogate marker for urine concentrating capacity, is associated with disease progression in adpkd

Use of copeptin in the diagnosis of polyuria-polydipsia syndrome

Determinants of urine volume in adpkd-patients using the vasopressin v2 receptor antagonist tolvaptan

Comparison of ex vivo stability of copeptin and vasopressin

The Effect of Renal Function and Hemodialysis Treatment on Plasma Vasopressin and Copeptin Levels

Read more